Ad is loading...
DGEYX
Price
$20.96
Change
-$0.19 (-0.90%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DGEYX vs RNWFX

Header iconDGEYX vs RNWFX Comparison
Open Charts DGEYX vs RNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - Y
Price$20.96
Change-$0.19 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DGEYX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGEYX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEYX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. DGEYX (395M). RNWFX pays higher dividends than DGEYX: RNWFX (1.51) vs DGEYX (1.00). DGEYX was incepted earlier than RNWFX: DGEYX (11 years) vs RNWFX (23 years). DGEYX is a more actively managed with annual turnover of: 44.72 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than DGEYX: RNWFX (250) vs DGEYX (1000000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. DGEYX (7.84). DGEYX return over 5 years is better than : 31.11 vs. RNWFX (17.17).
DGEYXRNWFXDGEYX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD3.9687.09956%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets395M60.9B1%
Annual Yield % from dividends1.001.5166%
Returns for 1 year7.8411.5468%
Returns for 3 years-26.27-14.55181%
Returns for 5 years31.1117.17181%
Returns for 10 years44.6141.00109%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics